Article

Bridge Capture permits cost-efficient, rapid and sensitive molecular precision diagnostics

2024-04-15

Abstract excerpt

Liquid biopsies are a less invasive alternative to tissue biopsies that have been the mainstay of cancer diagnostics to date. Recently, the quantification of mutations in circulating tumor DNA (ctDNA) by targeted next-generation sequencing (NGS) has been gaining popularity. Targeted NGS can be achieved through various library preparation methods, each with distinct advantages and limitations. Here we introduce Bri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89566381-6402-560f-915d-3054de0ef102
DOI: 10.1101/2024.04.12.24301526

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bridge Capture permits cost-efficient, rapid and sensitive molecular precision diagnosticsDOI 10.1101/2024.04.12.24301526Read

Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients.Semantic proximity Read

Rapid and highly-specific generation of targeted DNA sequencing libraries enabled by linking capture probes with universal primersSemantic proximity Read

Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden.Semantic proximity Read

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.Semantic proximity Read

Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsSemantic proximity Read

Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA.Semantic proximity Read

Comprehensive benchmarking of methods for mutation calling in circulating tumor DNASemantic proximity Read

Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Semantic proximity Read

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.Semantic proximity Read

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.Semantic proximity Read

Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter StudySemantic proximity Read

Findings from Precision Oncology in the Clinic: Rare, Novel Variants are a Significant Contributor to Scaling Molecular DiagnosticsSemantic proximity Read